Conversion Surgery Following Combination Treatment With Immune Checkpoint Inhibitors and Chemotherapy for Initially Unresectable Gastric Cancer | Synapse
The study aims to evaluate the effectiveness of conversion surgery after treatment with immune checkpoint inhibitors and chemotherapy for unresectable gastric cancer.
Analyzed cases of gastric cancer treated with immune checkpoint inhibitors and chemotherapy.
Evaluated patient eligibility for conversion surgery post-treatment.
Assessed surgical outcomes and survival rates.
Conversion surgery was performed successfully in a significant number of patients after initial treatment.
Patients showed improved survival rates compared to those who did not undergo surgery.
The approach indicates a promising strategy for managing unresectable gastric cancer.
Resumen
CS following combination treatment with ICI and chemotherapy may be promising for initially unresectable metastatic GC.